In addition, Resveratrol inhibits colorectal cancer progression by activating SIRT1, inhibiting the expression of the transcription factor FOXQ1, and controlling the regulatory promoter region of the 3′-UTR of the key autophagy molecule ATG16L, which triggers autophagy-related apoptosis 225. The gene discussed is SIRT1; the disease is colorectal cancer.